Browse by exact outcome

LDL cholesterol: every measured intervention

Ranked only against the same measurement, in the same unit. See the positive, neutral, opposite-direction and still-collecting evidence before deciding what is worth your own test.

How to read this

Observational research: real APOE4 carriers tracked over time, each compared with their own earlier self. Members chose their interventions, with no randomisation or placebo group. Everything else they changed is shown beside each result.

Read the full methods and limits

Questions about LDL cholesterol

What can improve LDL cholesterol for APOE4 carriers?

For APOE4 carriers, Phoenix has published positive evidence for Curcumin, Niacin, Ezetimibe, Probiotics, Psyllium, Statin family, Metformin, and Plain omega-3 against LDL cholesterol. Member #1EB8E9's LDL cholesterol moved from 151.4 to 120.3 mg/dL in 106 days. Member #4025C9's LDL cholesterol moved from 135 to 121 mg/dL in 255 days. Three members lowered LDL cholesterol in windows where ezetimibe was the most mechanistically established component of a larger combination. Two probiotic strains in two clean curated cases lowered LDL cholesterol by 32.7% and 26.1%. LDL cholesterol moved from 263 to 78 mg/dL in 70 days, but an undated ezetimibe entry may be the real actor. Member #5AA27F's longer arc moved LDL cholesterol from 161 to 49 mg/dL, about 70% lower; the aggregate statin effect remains unresolved. Member #2351C3's LDL cholesterol moved from 83 to 59 mg/dL in 881 days. Member #1EA5B3's LDL cholesterol moved from 129 to 99 mg/dL, down 23.3%, across a one-year clean window. Estradiol patch moved the opposite direction.

What has Phoenix measured against LDL cholesterol?

Phoenix has measured 9 interventions against LDL cholesterol: 8 positive, 1 opposite-direction. See the table below.

Every intervention measured against LDL cholesterol

Interventions measured against LDL cholesterol
InterventionWhat we observedEvidence status
CurcuminMember #1EB8E9's LDL cholesterol moved from 151.4 to 120.3 mg/dL in 106 days.Repeated positive
NiacinMember #4025C9's LDL cholesterol moved from 135 to 121 mg/dL in 255 days.Repeated positive
EzetimibeThree members lowered LDL cholesterol in windows where ezetimibe was the most mechanistically established component of a larger combination.Repeated positive
ProbioticsTwo probiotic strains in two clean curated cases lowered LDL cholesterol by 32.7% and 26.1%.Repeated positive
PsylliumLDL cholesterol moved from 263 to 78 mg/dL in 70 days, but an undated ezetimibe entry may be the real actor.Repeated positive
Statin familyMember #5AA27F's longer arc moved LDL cholesterol from 161 to 49 mg/dL, about 70% lower; the aggregate statin effect remains unresolved.Repeated positive
MetforminMember #2351C3's LDL cholesterol moved from 83 to 59 mg/dL in 881 days.Positive individual result
Plain omega-3Member #1EA5B3's LDL cholesterol moved from 129 to 99 mg/dL, down 23.3%, across a one-year clean window.Positive individual result
Estradiol patchMember #D9A2BF's LDL cholesterol moved opposite the goal, rising 13% while HDL and triglycerides improved.Opposite direction

Doesn't the brain need cholesterol? Can LDL go too low, and what LDL should a carrier aim for?

Lowering LDL lowers heart attacks and strokes, with no level found where the benefit stops, and pushing LDL very low with medicines did not harm memory in trials, including in APOE4 carriers. Your brain makes its own cholesterol, so blood LDL does not feed it. Whether lowering LDL prevents dementia is not yet proven, though high LDL in midlife goes with more dementia; Phoenix aims for LDL under 70 mg/dL (and ApoB under 60).

What the research says

Grade A

APOE4-specific evidence: limited

Lowering LDL cuts heart attacks and strokes and does not harm memory even at very low levels (high certainty); whether it prevents dementia is unproven.

Key studies

  • Cholesterol Treatment Trialists 2010, LancetGrade A

    26 trials, 170,000 people: each 39 mg/dL lower LDL cut major vascular events about a fifth, with no lower limit seen.

    Read on PubMed (opens in a new tab)
  • Lee 2026, N Engl J Med (EZ-PAVE)Grade A

    EZ-PAVE, 3,048 people with heart disease: aiming for LDL under 55 instead of under 70 cut events by a third.

    Read on PubMed (opens in a new tab)
  • Giugliano 2017, N Engl J Med (EBBINGHAUS)Grade A

    EBBINGHAUS trial: very low LDL on evolocumab did not change memory or thinking versus placebo.

    Read on PubMed (opens in a new tab)
7 more key studies

What Kevin and experts say

6 passages for, 2 with a caution, 3 also discussed

Now showing: Dr. Kevin Tran · 0:04

Open on YouTube (opens in a new tab)

For6 passages

  1. 0:04How Ezetimibe Took My ApoB Down Nearly 40% (APOE4/4, No Statin) ·

    Kevin cut ApoB nearly 40% with stacked levers, no statin.

    “when I first had my apoB measured, it was 115 mg per deciliter. Today, it's slightly below 70, and that's a drop of nearly 40%.”

    Dr. Kevin Tran, Founder of The Phoenix Community, Doctor of Pharmacy, APOE4/4 carrier

  2. 11:58How Ezetimibe Took My ApoB Down Nearly 40% (APOE4/4, No Statin) ·

    Carriers' cholesterol responds more to diet.

    “blood cholesterol in APOE4 carriers appear more responsive to changes in dietary cholesterol and fat consumption than in non-carriers”

    Dr. Kevin Tran, Founder of The Phoenix Community, Doctor of Pharmacy, APOE4/4 carrier

  3. 27:26How Ezetimibe Took My ApoB Down Nearly 40% (APOE4/4, No Statin) ·

    Lowering blood cholesterol does not starve your brain.

    “Monoclonal antibodies, especially PCSK9 inhibitors, ezetimibe, and bempedoic acid appear neurocognitively safe, and peripheral cholesterol lowering does not starve your brain”

    Dr. Kevin Tran, Founder of The Phoenix Community, Doctor of Pharmacy, APOE4/4 carrier

  4. 30:11How Ezetimibe Took My ApoB Down Nearly 40% (APOE4/4, No Statin) ·

    In heart patients, a lower LDL target cut events by a third.

    “So, the hazard ratio was 0.67, confidence interval 0.52 to 0.86, which is a 33% relative risk reduction, driven primarily by reductions in non-fatal MI and revascularization.”

    Dr. Kevin Tran, Founder of The Phoenix Community, Doctor of Pharmacy, APOE4/4 carrier

  5. ShortPsyllium vs inulin: only one lowers LDL. ·

    Psyllium fiber lowers LDL and ApoB modestly.

    Dr. Kevin Tran

    Watch the Short on YouTube (opens in a new tab)
  6. ShortFour Diet Moves for APOE4 Carriers ·

    Kevin cut butter, cheese and fatty red meat.

    Dr. Kevin Tran

    Watch the Short on YouTube (opens in a new tab)

With a caution2 passages

  1. 13:28APOE4: When Is It Too Late To Prevent Alzheimer's? ·

    High midlife LDL is a dementia risk factor.

    “High LDL cholesterol in midlife now accounts for an estimated of 7% of dementia cases.”

    Dr. Kevin Tran, Founder of The Phoenix Community, Doctor of Pharmacy, APOE4/4 carrier

  2. 47:13APOE4 & Lipids: Why Your Doctor's Targets Aren't Aggressive Enough (Statin Debate Settled?) ·

    LDL can mislead; ApoB is more accurate.

    “there's a discordance in about 15% of people”

    Dr. Grant Fraser, Board-certified anti-aging and family medicine physician, APOE4 carrier

Also discussed3 passages

  1. 27:38How Ezetimibe Took My ApoB Down Nearly 40% (APOE4/4, No Statin) ·

    Your brain makes its own cholesterol.

    “there's essentially no cholesterol that enters the brain from the peripheral circulation”

    Dr. Kevin Tran, Founder of The Phoenix Community, Doctor of Pharmacy, APOE4/4 carrier

  2. 28:38APOE4 and Menopause: Have You Missed the HRT Window? A Neurologist expert opinion. ·

    Perimenopause can push LDL up sharply in some women.

    “suddenly they have a cholesterol of 250 and an LDL that's jumped up to 140”

    Dr. Ashanthi Gajaweera, Board-certified neurologist, Menopause Society certified practitioner (Healthspan Neurology)

  3. ShortA Guideline + 2 Trials Rewrote the Ezetimibe Story (2026) ·

    New guideline: tighter LDL targets and ApoB now endorsed.

    Dr. Kevin Tran

    Watch the Short on YouTube (opens in a new tab)

Last reviewed

What changed for real APOE4 carriers?

Search by health goal or intervention to see what changed for real members, including results that moved the wrong way.

Want to move your LDL cholesterol? Phoenix tracks what you try against it and checks your labs against APOE4 ranges.

Apply to join Phoenix

Cholesterol and heart risk · Lower LDL cholesterol · 12 interventions shown.

Health goalCholesterol and heart risk
SubgoalLower LDL cholesterol

Lower LDL cholesterol

Interventions tested: 12

Curcumin

SupplementsOutcomes: 1

LDL cholesterol: Decrease 31.1–52 mg/dL

Cases: 2Case range

Estradiol patch

MedicationsOutcomes: 1

LDL cholesterol: Decrease 15.1 mg/dL

Cases: 2

Ezetimibe

MedicationsOutcomes: 1

LDL cholesterol: Decrease 22–52 mg/dL

Cases: 4Case range

Lithium orotate

SupplementsOutcomes: 1

LDL cholesterol: Decrease 15 %

Cases: 1

Context affected

Metformin

MedicationsOutcomes: 1

LDL cholesterol: Decrease 24 mg/dL

Cases: 1

Niacin

SupplementsOutcomes: 1

LDL cholesterol: Decrease 12–14 mg/dL

Cases: 2Case range

NMN

SupplementsOutcomes: 1

LDL cholesterol: Decrease 26.3 %

Cases: 1

Context affected

Plain omega-3

SupplementsOutcomes: 1

LDL cholesterol: Decrease 30 mg/dL

Cases: 1

Probiotics

SupplementsOutcomes: 1

LDL cholesterol: Decrease 32–41 mg/dL

Cases: 2Case range

Psyllium

SupplementsOutcomes: 1

LDL cholesterol: Decrease 4–185 mg/dL

Cases: 2Case range

Statin family

MedicationsOutcomes: 1

LDL cholesterol: Decrease 6–112 mg/dL

Cases: 4Case range

Vitamin D3

SupplementsOutcomes: 1

LDL cholesterol: Increase 26 %

Cases: 1

Under review

The Beat the Odds Study

The 43-page study: what members tried, how their bloodwork and wearable results changed, and what else changed alongside them.

Download the Beat the Odds Study

Turn evidence into your next test

I built this so nobody has to be the first to try something.

476 members have already tried, measured and logged. Join Phoenix and your next blood draw joins the same Navigator you are reading.

Apply to join Phoenix

Full research index

Find a goal, marker, intervention or question

Choose an outcome, like LDL cholesterol or sleep, or an intervention, like training: both paths open the same measured records.